Skip to main content
. 2022 Mar 17;9:817826. doi: 10.3389/fcvm.2022.817826

FIGURE 1.

FIGURE 1

Flow of the patients. A prospective, multicentre cross-sectional study was conducted to test the accuracy of a heparin-calibrated anti-Xa assay for the measurement of rivaroxaban, apixaban, or edoxaban plasma levels in clinical practice.